- Artificial intelligence (AI) tools could enable men to get PCa treatment that’s more personalised to them, saving and extending lives, according to new research. More here
- Newsletter
We are to email two newsletters a year to members in future. David Casley, Prospect Publicity 07860 369064; Email prospect.bristol@gmail.com
News
Scientists reverse drug resistance in PCa by targeting ‘hijacked’ white blood cells (Oct ’23). See here
Member Colin Butcher has written an article to help cancer patients and plans more. Find it here
A new drug combination could revolutionise the treatment of advanced PCa and give sufferers months of extra life. More here And NICE has approved darolutamide in combination with hormone therapy and chemotherapy for men with hormone-sensitive advanced PCa. It’s estimated around 6,000 men could benefit (Jun ’23). More here And researchers have found that targeting a single enzyme, called PI5P4Kα, can kill PCa cells, including those that have developed resistance to traditional treatments. More here
Former England striker Mick Harford wants to unite football fans to join Prostate Cancer FC, raise awareness of the risk factors, fund research and save lives in every club across the UK (Feb 23). See more here
Facebook has a new site for women affected by a partner’s PCa. See here
This new test for PCa has 94pc accuracy (Feb 23). See here
Scientists discovered a single bout of exercise can suppress tumour growth and actively fight cancerous cells – even in those with incurable, advanced cancer (Jan ’23). More here And getting active doesn’t have to be boring. Here are some tips to help put the fun firmly into fitness. And there’s a YouTube talk about the benefits of running here
A DRUG that works like a ‘poison arrow’ could transform the treatment of men who have the deadliest prostate cancers. The two-in-one treatment wiped out lethal tumours in lab tests, and trials were starting on British men within weeks (Dec ’22). Download poison-arrow-drug.rtf